After the company Pfizer Inc announced on Wednesday that the Covid vaccine it developed with BioNTech showed 95% efficacy in the final phase 3 trial, BioNTech CEO Ugur Sahin told Reuters that the Vaccine deliveries could start before Christmas.
Featured statements:
“If all goes well, you could imagine we get approval in the second half of December and start deliveries before Christmasbut really only if everything goes well. ”
“The US emergency use authorization would be requested on Friday.”
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
